Long wait over, Discovery Labs launches premature infant drug
Discovery Laboratories Inc. launched Surfaxin Friday, eight years after first seeking Food and Drug Administration approval for the product. Surfaxin was approved last year for use in preventing respiratory distress syndrome in premature infants. The compound is the first FDA-approved synthetic, peptide-containing surfactant a substance found in the lungs that is essential for breathing.
Newborn baby is borderline; should the doctor resuscitate?
The newborn resuscitation room was uncomfortably hot the thermostat was set high to prevent a just-born babys body temperature from dropping rapidly. Our neonatology team was finishing up paperwork on a baby we had just resuscitated and stabilized when a nurse from obstetrics popped her head in: Dont leave yet! A 23-weeker just rolled in; she might deliver soon!
East Lancashire's smallest 1lb 6oz baby astonishing doctors
A baby born four months premature, weighing just 1lb 6oz, has stunned doctors with his astonishing progress. Tiny Jordan James McCormack, one of the smallest babies born in East Lancashire, has battled through seven blood and platelet transfusions and a lung infection. He was born 17 weeks early and weighed just 22 ounces at birth, less than an iPad.
Breast Milk Donated or Sold Online Is Often Tainted, Study Says
A cottage industry has sprung up facilitating the sale and donation of human breast milk on the Internet, but a study published Monday in the journal Pediatrics confirms the concerns of health professionals over this unregulated marketplace.
The parental consent dilemma: Saving extremely premature babies by signing forms
Our baby was dying a half-dozen ways. She was born in the 23rd week of pregnancy weighing 1 pound, 4 ounces. Twiggy and translucent, her body heaved along with the mechanical whooshing of a ventilator that kept her alive while battering her lungs. No matter what the doctors did, she would probably end up dead or broken.
Even early term is too early
Although most of us used to think that full-term neonates born between 37 and 41 weeks gestation were, as a whole, a low-risk group, research continues to show that tremendous variation exists within this 5-week period, and that although these babies may look healthy, those born early term (at 37 or 38 weeks) have significantly higher rates of problems than those born between 39 and 41 weeks.